Top Tweets for #cardioDrop

5 days ago

#CardioDrop #ThingsNoOneAsked #SciSess2026 @AHAScience Per guidelines, optimal chest compressions for best CV outcomes in CPR: 📍Hand position: Heel of hand on lower ½ sternum; pt on firm surface. 📍Depth: ≥5 cm. Better survival vs <4 cm; >6 cm linked to lower survival. 📍Rate: 100–120/min. Highest survival to discharge; 121–140/min ↑ROSC in 1 study. 📍Recoil: No leaning between compressions. 📍Min pauses: Short pauses. Resume immediately post-shock; no rhythm/pulse check. 🎯Shoulder-elbow-heel of the hand in line, keeping elbow extended.

AgadiKuchal's tweet photo. #CardioDrop #ThingsNoOneAsked #SciSess2026
@AHAScience Per guidelines, optimal chest compressions for best CV outcomes in CPR:
📍Hand position: Heel of hand on lower ½ sternum; pt on firm surface.
📍Depth: ≥5 cm. Better survival vs <4 cm; >6 cm linked to lower survival.
📍Rate: 100–120/min. Highest survival to discharge; 121–140/min ↑ROSC in 1 study.
📍Recoil: No leaning between compressions.
📍Min pauses: Short pauses. Resume immediately post-shock; no rhythm/pulse check.

🎯Shoulder-elbow-heel of the hand in line, keeping elbow extended.

Kuchal Agadi

@AgadiKuchal

6 days ago

#cardioDrop #ThingsthatIdothatnooneaskedmeto Day 1 @AHAScience 5th Universal Definition of MI 🫀 Here is what’s new and why it matters from #ScientificSessions26: 📍What’s New: • Procedure-Related MI: Tightened criteria down to coronary complications arising strictly within 30 days of a cardiac procedure. • Objective Mandate: Diagnosis now strictly requires objective cardiac imaging criteria—such as angiographic evidence of a complication or a new regional wall motion abnormality. • Secondary MI Defined: Confirmed via ≥70% stenosis in an epicardial vessel (or ≥50% with physiological flow limitations) without acute coronary pathology. 📍Why It Matters: • Prioritizes Specificity: Eliminates diagnostic gray areas by anchoring definitions in definitive visual data. • Cleaner Data: Excludes late stent or graft failures to ensure procedural complications only reflect de novo disease. • Fewer "Mimickers": Helps clinicians clearly differentiate true ischemia from chronic troponin elevators like ESRD, Sepsis, and Heart Failure. #Cardiology #AHA26 #MedX #FOAMed -

AgadiKuchal's tweet photo. #cardioDrop
#ThingsthatIdothatnooneaskedmeto
Day 1 @AHAScience

5th Universal Definition of MI 🫀
Here is what’s new and why it matters from #ScientificSessions26:

📍What’s New:
• Procedure-Related MI: Tightened criteria down to coronary complications arising strictly within 30 days of a cardiac procedure.
• Objective Mandate: Diagnosis now strictly requires objective cardiac imaging criteria—such as angiographic evidence of a complication or a new regional wall motion abnormality.
• Secondary MI Defined: Confirmed via ≥70% stenosis in an epicardial vessel (or ≥50% with physiological flow limitations) without acute coronary pathology.

📍Why It Matters:
• Prioritizes Specificity: Eliminates diagnostic gray areas by anchoring definitions in definitive visual data.
• Cleaner Data: Excludes late stent or graft failures to ensure procedural complications only reflect de novo disease.
• Fewer "Mimickers": Helps clinicians clearly differentiate true ischemia from chronic troponin elevators like ESRD, Sepsis, and Heart Failure.
#Cardiology #AHA26 #MedX #FOAMed

-

180

Kuchal Agadi

@AgadiKuchal

6 days ago

#CardioDrop #thingIdothatIdothatnooneaskedmeto Day 1 @AHAScience Agentic AI 🤖 is moving into cardiovascular care—but autonomy has to be earned, not assumed. At #AHA26 QCOR, a clear framework for any clinical agent: ✅ Task — What will it do (and not do)? Clinical owner ✅ Model — Which version, tested on our patients? AI governance ✅ Data — Only the data it needs? Privacy/IRB ✅ Tools — What can it change? What’s locked? IT security ✅ Prompt — Who can change its instructions? Clinical owner ✅ Guardrails — Who watches, and who stops it? Patient safety & quality ✈️ auto land after evidence 🚗 driving (safety driver first 💊 prescribing, clinician signs 👨👩 steps back only with proof & 🤖must step back if there’s an incident. 🎯safe, evidence-based digital teammates that expand access—especially for heart failure patients who lack consistent specialty care. 📍What’s your non-negotiable before letting an agent touch a care pathway? #AgenticAI #CardiovascularCare #AHA26 #DigitalHealth #PatientSafety

AgadiKuchal's tweet photo. #CardioDrop #thingIdothatIdothatnooneaskedmeto
Day 1 @AHAScience

Agentic AI 🤖 is moving into cardiovascular care—but autonomy has to be earned, not assumed.

At #AHA26 QCOR, a clear framework for any clinical agent:
✅ Task — What will it do (and not do)? Clinical owner
✅ Model — Which version, tested on our patients? AI governance
✅ Data — Only the data it needs? Privacy/IRB
✅ Tools — What can it change? What’s locked? IT security
✅ Prompt — Who can change its instructions? Clinical owner
✅ Guardrails — Who watches, and who stops it? Patient safety & quality

✈️ auto land after evidence
🚗 driving (safety driver first
💊 prescribing, clinician signs

👨👩 steps back only with proof & 🤖must step back if there’s an incident.

🎯safe, evidence-based digital teammates that expand access—especially for heart failure patients who lack consistent specialty care.

📍What’s your non-negotiable before letting an agent touch a care pathway?
#AgenticAI #CardiovascularCare #AHA26 #DigitalHealth #PatientSafety

Kuchal Agadi

@AgadiKuchal

3 months ago

#CardioDrop Debate Common scenario in my PCP basket: 🫀 35-year-old, TC 200, HDL 40, LDL-C 158 mg/dL, not diabetic, normal BP, smoker, normal BMI, negative family history. What should be done: 🧡 Statin now… or 🧡 Lifestyle changes + recheck lipids in 3–5 years? 🧡 Lp(a) and/or CAC is the tiebreaker 🎭 Team Early Statin ~ Every year of elevated LDL = increased plaque burden—especially if 30-year risk looks more concerning even when 10-year risk is tiny. 🎭 Team Lifestyle ~ This is a Class 1 recommendation ~ PREVENT usually yields lower risk estimates; absolute benefit is small. Start pharmacotherapy for clearer signals (LDL ≥160, risk enhancers, high 30-year risk, or patient preference after discussion). ⭐️ New 2026 ACC/AHA Multisociety Dyslipidemia Guideline Class 1 For true low-risk patients (<3% 10-year): lifestyle counseling Class 2a Moderate-intensity statin is reasonable if LDL-C is 160–189 or 30-year ASCVD risk ≥10%. How would you proceed? Is Lp(a)/CAC the 🏆 #Medtwitter #FOAMED @rblument1 @DrMarthaGulati

Kuchal Agadi

@AgadiKuchal

over 1 year ago

(DOACs)❌ Warfarin ✅ in: 🫀Mechanical Heart Valves 🫀Moderate to Severe Rheumatic Mitral Stenosis with Atrial Fibrillation 🫀Triple-positive Antiphospholipid Syndrome (APS) #cardiodrop #Medtwitter

AgadiKuchal's tweet photo. (DOACs)❌ Warfarin ✅ in:

🫀Mechanical Heart Valves
🫀Moderate to Severe Rheumatic Mitral Stenosis with Atrial Fibrillation
🫀Triple-positive Antiphospholipid Syndrome (APS)

#cardiodrop #Medtwitter https://t.co/8avW8HRnjr

Kuchal Agadi

@AgadiKuchal

over 1 year ago

What’s #Cardiodrop ? A saying in Tamil which translates to “what you know is in the size of a drop, what ought to be learnt in size of the ocean” - #Cardiodrop | #meddrop tiny bit of information I plan on sharing here daily🍀 🧿#MedTwitter

Top Tweets for #cardioDrop

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users